Legend Biotech Corp (LEGN) Most Active Options
The 20 most actively traded Legend Biotech Corp (LEGN) option contracts at the latest daily snapshot, ranked by volume. Each row shows the contract's price, implied volatility, delta, open interest, and how today's volume compares with its own 30-day average — click a contract to analyze it in the OptiView platform.
Data as of Jul 10, 2026, 8:00 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.
Most Active LEGN Contracts
| Contract | Expiration | DTE | Last | IV | IV rank (30d) | Delta | Open interest | Volume | vs 30d avg |
|---|---|---|---|---|---|---|---|---|---|
| LEGN $30 call | Jul 17, 2026 | 7d | $0.30 | 79.4% | 11 | 0.19 | 1,003 | 444 | 3.8× avg |
| LEGN $27.5 call | Jul 17, 2026 | 7d | $0.70 | 95.7% | 0 | 0.48 | 41 | 213 | 1.6× avg |
| LEGN $25 call | Aug 21, 2026 | 42d | $3.40 | 61.5% | 39 | 0.69 | 1,332 | 200 | 6.9× avg |
| LEGN $25 put | Aug 21, 2026 | 42d | $0.98 | 58.0% | 29 | -0.30 | 554 | 135 | 15.0× avg |
| LEGN $25 call | Sep 18, 2026 | 70d | $3.90 | 62.6% | 41 | 0.68 | 572 | 123 | 4.3× avg |
| LEGN $27.5 put | Jul 17, 2026 | 7d | $1.00 | 68.9% | 10 | -0.54 | 245 | 91 | 2.8× avg |
| LEGN $27.5 put | Sep 18, 2026 | 70d | $3.10 | 40.3% | 0 | -0.48 | 70 | 25 | 3.9× avg |
| LEGN $22.5 put | Dec 18, 2026 | 161d | $1.80 | 57.0% | 24 | -0.24 | 193 | 21 | 19.7× avg |
| LEGN $22.5 put | Nov 20, 2026 | 133d | $1.72 | 58.8% | 28 | -0.23 | 31 | 20 | 18.7× avg |
| LEGN $25 call | Jan 15, 2027 | 189d | $5.50 | 56.4% | 25 | 0.67 | 496 | 20 | 5.8× avg |
| LEGN $50 call | Jan 15, 2027 | 189d | $0.65 | 65.3% | 43 | 0.15 | 74 | 16 | 8.8× avg |
| LEGN $30 call | Aug 21, 2026 | 42d | $1.18 | 57.8% | 28 | 0.34 | 592 | 9 | 0.7× avg |
| LEGN $37.5 call | Sep 18, 2026 | 70d | $0.50 | 66.1% | 12 | 0.17 | 1,471 | 7 | 0.7× avg |
| LEGN $35 call | Jul 17, 2026 | 7d | $0.05 | 122.5% | 0 | 0.08 | 115 | 6 | 0.7× avg |
| LEGN $27.5 call | Sep 18, 2026 | 70d | $2.50 | 53.5% | 30 | 0.53 | 83 | 4 | 0.3× avg |
| LEGN $40 call | Jan 15, 2027 | 189d | $1.52 | 69.8% | 52 | 0.31 | 67 | 3 | 1.6× avg |
| LEGN $37.5 call | Mar 19, 2027 | 252d | $2.47 | 60.3% | 40 | 0.36 | 743 | 3 | 0.2× avg |
| LEGN $40 call | Mar 19, 2027 | 252d | $2.05 | 56.1% | 24 | 0.29 | 37 | 3 | 1.6× avg |
| LEGN $40 call | Jul 17, 2026 | 7d | $0.05 | 148.2% | 0 | 0.04 | 145 | 2 | 4.0× avg |
| LEGN $32.5 call | Jan 15, 2027 | 189d | $2.69 | 58.2% | 34 | 0.43 | 52 | 1 | 0.1× avg |
Ranked by volume at the latest daily snapshot. "vs 30d avg" compares today's volume with the contract's own 30-day average.
The most active LEGN contract today is the $30 call expiring in 7 days, with 444 contracts traded. Calls dominate the most-active list (15 of the top 20), showing where trading interest concentrates.
Explore the payoff profile of option on LEGN for free
Build multi-leg LEGN strategies, visualize payoffs, and scan the full US options universe with OptiView.
LEGN Options FAQ
Which LEGN option contract is most active today?
The most traded LEGN contract is the $30 call expiring Jul 17, 2026, with 444 contracts traded as of Jul 10, 2026.
How does OptiView rank the most active LEGN options?
The table lists the 20 LEGN contracts with the highest volume at the latest daily snapshot, alongside price, implied volatility, delta, open interest, and each contract's volume versus its own 30-day average.
Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.
Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.